Madrigal Pharmaceuticals Inc. (MDGL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Madrigal Pharmaceuticals ...

    NASDAQ: MDGL · Real-Time Price · USD
    424.23
    1.24 (0.29%)
    At close: Sep 26, 2025, 3:59 PM
    423.48
    -0.18%
    After-hours: Sep 26, 2025, 07:57 PM EDT

    Madrigal Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 180.13M n/a n/a n/a
    Cost of Revenue
    		 7.33M 527K 467K 405K
    Gross Profit
    		 172.8M -527K -467K -405K
    Operating Income
    		 -497.88M -380.5M -293.57M -241.98M
    Interest Income
    		 46.65M 19.58M 2.19M 363K
    Pretax Income
    		 -465.89M -373.63M -295.35M -241.85M
    Net Income
    		 -465.89M -373.63M -295.35M -241.85M
    Selling & General & Admin
    		 435.06M 108.15M 48.13M 37.32M
    Research & Development
    		 236.72M 271.82M 245.44M 205.16M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 670.68M 379.97M 293.1M 241.58M
    Interest Expense
    		 14.67M 12.71M 3.96M n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 678.01M 380.5M 293.57M 242.48M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 21.27M 18.69M 17.14M 16.54M
    Shares Outstanding (Diluted)
    		 21.27M 18.69M 17.14M 16.54M
    EPS (Basic)
    		 -21.9 -19.99 -17.23 -14.63
    EPS (Diluted)
    		 -21.9 -19.99 -17.23 -14.63
    EBITDA
    		 -450.13M -360.39M -290.92M -241.44M
    EBIT
    		 -451.22M -360.92M -291.39M -241.85M
    Depreciation & Amortization
    		 1.1M 527K 467K 405K

    Add to Watchlist